Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,943 | 11,815 | 13,693 | 19,192 | 9,000 |
| Receivables | 1,665 | 1,674 | 2,459 | 2,347 | 744 |
| TOTAL | $21,735 | $14,768 | $16,993 | $22,023 | $10,910 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $21,735 | $14,768 | $16,993 | $22,023 | $10,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,993 | 2,925 | 2,090 | 3,465 | 3,461 |
| TOTAL | $3,346 | $4,278 | $2,501 | $3,465 | $3,461 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,353 | 1,353 | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,346 | $4,278 | $2,501 | $3,465 | $3,461 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,673 | 12,939 | 11,315 | 10,709 | 8,923 |
| Common Shares | 17 | 11 | 11 | 11 | 9 |
| Retained earnings | -457,478 | -455,479 | -451,463 | -447,017 | -443,180 |
| TOTAL | $18,389 | $10,490 | $14,492 | $18,558 | $7,450 |
| Total Liabilities And Equity | $21,735 | $14,768 | $16,993 | $22,023 | $10,910 |